SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
  
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
1. Name and Address of Reporting Person*
CLEARLAKE CAPITAL GROUP, L.P.

(Last) (First) (Middle)
C/O JANUS INTERNATIONAL GROUP, INC.
135 JANUS INTERNATIONAL BLVD.

(Street)
TEMPLE GA 30179

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Janus International Group, Inc. [ JBI ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director X 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
11/12/2021
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock, par value $0.0001 per share ("Common Stock") 11/12/2021 M(1) 29,990 A $0.00 445,240 I See footnotes(2)(8)(9)(10)
Common Stock 11/12/2021 F(1) 20,993 D $0.00 424,247 I See footnotes(2)(8)(9)(10)
Common Stock 11/12/2021 M(1) 80,898 A $0.00 1,201,017 I See footnotes(3)(8)(9)(10)
Common Stock 11/12/2021 F(1) 56,629 D $0.00 1,144,388 I See footnotes(3)(8)(9)(10)
Common Stock 11/12/2021 M(1) 1,850,395 A $0.00 27,471,472 I See footnotes(4)(8)(9)(10)
Common Stock 11/12/2021 F(1) 1,295,277 D $0.00 26,176,195 I See footnotes(4)(8)(9)(10)
Common Stock 11/12/2021 M(1) 124,088 A $0.00 1,842,225 I See footnotes(5)(8)(9)(10)
Common Stock 11/12/2021 F(1) 86,862 D $0.00 1,755,363 I See footnotes(5)(8)(9)(10)
Common Stock 11/12/2021 M(1) 923,053 A $0.00 13,703,894 I See footnotes(6)(8)(9)(10)
Common Stock 11/12/2021 F(1) 646,138 D $0.00 13,057,756 I See footnotes(6)(8)(9)(10)
Common Stock 11/12/2021 M(1) 808,802 A $0.00 12,007,763 I See footnotes(7)(8)(9)(10)
Common Stock 11/12/2021 F(1) 566,162 D $0.00 11,441,601 I See footnotes(7)(8)(9)(10)
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Warrants $11.5 11/12/2021 M 29,990 07/07/2021 06/07/2026 Common Stock 29,990 $0.00 0 I See footnotes(2)(8)(9)(10)
Warrants $11.5 11/12/2021 M 80,898 07/07/2021 06/07/2026 Common Stock 80,898 $0.00 0 I See footnotes(3)(8)(9)(10)
Warrants $11.5 11/12/2021 M 1,850,395 07/07/2021 06/07/2026 Common Stock 1,850,395 $0.00 0 I See footnotes(4)(8)(9)(10)
Warrants $11.5 11/12/2021 M 124,088 07/07/2021 06/07/2026 Common Stock 124,088 $0.00 0 I See footnotes(5)(8)(9)(10)
Warrants $11.5 11/12/2021 M 923,053 07/07/2021 06/07/2026 Common Stock 923,053 $0.00 0 I See footnotes(6)(8)(9)(10)
Warrants $11.5 11/12/2021 M 808,802 07/07/2021 06/07/2026 Common Stock 808,802 $0.00 0 I See footnotes(7)(8)(9)(10)
Explanation of Responses:
1. On October 13, 2021, Janus International Group, Inc. ("Janus") delivered a notice of redemption to holders of all outstanding warrants (the "Warrants") to purchase shares of Common Stock, par value $0.0001 per share (the "Common Stock"). Pursuant to the terms of the outstanding warrant agreements applicable to the Warrants, the Reporting Person elected to exercise all Warrants on a cashless basis.
2. Securities held of record by Clearlake Capital Partners IV (AIV-Jupiter) USTE, L.P., a Cayman Islands limited partnership ("CCPIV USTE").
3. Securities held of record by Clearlake Capital Partners IV (Offshore), L.P., a Cayman Islands limited partnership ("CCPIV Offshore").
4. Securities held of record by Clearlake Capital Partners V, L.P., a Delaware limited partnership ("CCPV").
5. Securities held of record by Clearlake Capital Partners V (USTE), L.P., a Delaware limited partnership ("CCPV USTE").
6. Securities held of record by Clearlake Capital Partners V (Offshore), L.P., a Cayman Islands limited partnership ("CCPV Offshore").
7. Securities held of record by Clearlake Capital Partners IV (AIV-Jupiter), L.P., a Cayman Islands limited partnership ("CCPIV").
8. CCPIV, CCPIV USTE and CCPIV Offshore are managed by Clearlake Capital Management IV, L.P., a Delaware limited partnership ("CCMIV"). CCMIV's general partner is Clearlake Capital Group, L.P., whose general partner is CCG Operations, L.L.C., a Delaware limited liability company ("CCG Ops"). The general partner for each of CCPIV, CCPIV USTE and CCPIV Offshore is Clearlake Capital Partners IV GP, L.P., a Delaware limited partnership ("CCPIV GP"). CCPIV GP's general partner is Clearlake Capital Partners, LLC, a Delaware limited liability company ("CCP"). CCPV, CCPV USTE and CCPV Offshore are managed by Clearlake Capital Management V, L.P., a Delaware limited partnership ("CCMV"). CCMV's general partner is Clearlake Capital Group, L.P., whose general partner is CCG Ops.
9. (Continued from Footnote 8) The general partner for each of CCPV, CCPV USTE and CCPV Offshore is Clearlake Capital Partners V GP, L.P., a Delaware limited partnership ("CCPV GP"). CCPV GP's general partner is CCP. CCP's managing member is CCP MM, LLC, a Delaware limited liability company ("CCP MM"). CCP MM's managing member is CCG Ops. CCG Global LLC, a Delaware liability company ("CCG Global"), is the managing member of CCG Ops.
10. The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of all of the reported securities for purposes of Section 16 or for any other purpose.
Remarks:
On June 7, 2021, the Reporting Person appointed Jose E. Feliciano and Colin Leonard to the board of directors of Janus. On the basis of the relationship between Mr. Feliciano and Mr. Leonard, on the one hand, and the Reporting Person, on the other, the Reporting Person may be deemed a director by deputization in respect of Janus.
/s/ Scott Sannes, as Attorney-in-Fact for Clearlake Capital Group, L.P. 11/16/2021
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.